GOLDMAN SACHS GROUP INC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,604,019
+35.3%
194,649
+39.1%
0.00%0.0%
Q2 2023$10,056,017
-39.5%
139,939
-48.0%
0.00%
-50.0%
Q1 2023$16,611,657
-24.7%
269,320
-5.8%
0.00%
-20.0%
Q4 2022$22,062,188
-4.8%
286,039
-44.9%
0.01%0.0%
Q3 2022$23,170,000
+60.3%
519,264
+37.6%
0.01%
+66.7%
Q2 2022$14,452,000
+500.7%
377,337
+549.0%
0.00%
+200.0%
Q1 2022$2,406,000
-20.4%
58,137
-27.4%
0.00%0.0%
Q4 2021$3,024,000
+110.0%
80,050
+83.1%
0.00%
Q3 2021$1,440,000
-49.2%
43,709
+4.0%
0.00%
-100.0%
Q2 2021$2,835,000
-64.9%
42,028
-70.5%
0.00%
-50.0%
Q1 2021$8,079,000
-49.9%
142,690
-27.9%
0.00%
-50.0%
Q4 2020$16,114,000
-31.6%
197,796
-40.1%
0.00%
-42.9%
Q3 2020$23,545,000
-31.2%
330,457
-20.6%
0.01%
-30.0%
Q2 2020$34,246,000
+136.9%
416,210
+69.4%
0.01%
+100.0%
Q1 2020$14,455,000
-31.4%
245,707
+20.6%
0.01%0.0%
Q4 2019$21,066,000
+3342.2%
203,808
+574.4%
0.01%
Q3 2019$612,000
+8.1%
30,220
+37.4%
0.00%
Q2 2019$566,000
-41.5%
21,992
-67.7%
0.00%
Q1 2019$968,000
+306.7%
68,053
+60.2%
0.00%
Q4 2017$238,000
-36.0%
42,473
-37.2%
0.00%
Q2 2017$372,000
+207.4%
67,618
+118.7%
0.00%
Q1 2017$121,000
-10.4%
30,920
+73.2%
0.00%
Q2 2016$135,000
-40.3%
17,854
-26.9%
0.00%
Q4 2015$226,00024,4260.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders